EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease
- PMID: 17293007
- DOI: 10.1016/j.neurobiolaging.2006.12.019
EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease
Abstract
Identification of preclinical markers is required for early diagnosis of Alzheimer's disease (AD) and cognitive dysfunction in advancing age. Quantitative EEG was examined in 145 individuals with AD, their unaffected relatives and unrelated individuals. The AD patients and their relatives were stratified by ApoE genotype. The resting EEG parameters were severely changed in AD patients, and in patients carrying the ApoE epsilon4 allele the decrease in alpha power was higher than in epsilon4 non-carriers. The resting EEG parameters were indistinguishable in AD relatives with different ApoE genotypes and similar to EEG pattern in common population. Under hyperventilation the presence of the epsilon4 allele in AD relatives was associated with the manifestation of synchronous high-voltage delta-, theta-activity and sharp-waves, pronounced decrease in alpha and increase in delta and theta relative powers. The data suggest that neurophysiological endophenotype of non-demented individuals at genetic risk for AD, characterized by increased excitability and dysfunction of deep brain and alpha rhythm-generating structures, may be revealed decades before the first clinical symptoms of presumable dementia.
Similar articles
-
APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.Arch Neurol. 2004 Dec;61(12):1930-4. doi: 10.1001/archneur.61.12.1930. Arch Neurol. 2004. PMID: 15596614
-
Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study.Ann Neurol. 2006 Feb;59(2):323-34. doi: 10.1002/ana.20724. Ann Neurol. 2006. PMID: 16358334
-
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.J Nucl Med. 2005 Oct;46(10):1625-32. J Nucl Med. 2005. PMID: 16204712 Clinical Trial.
-
Pharmacogenomics in Alzheimer's disease.Methods Mol Biol. 2008;448:213-357. doi: 10.1007/978-1-59745-205-2_10. Methods Mol Biol. 2008. PMID: 18370236 Review.
-
Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Methods Find Exp Clin Pharmacol. 2007 Jul;29 Suppl A:1-91. Methods Find Exp Clin Pharmacol. 2007. PMID: 17957277 Review.
Cited by
-
Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments.Front Comput Neurosci. 2012 Jul 23;6:52. doi: 10.3389/fncom.2012.00052. eCollection 2012. Front Comput Neurosci. 2012. PMID: 22837746 Free PMC article.
-
The combination of hyperventilation test and graph theory parameters to characterize EEG changes in mild cognitive impairment (MCI) condition.Geroscience. 2023 Jun;45(3):1857-1867. doi: 10.1007/s11357-023-00733-5. Epub 2023 Jan 24. Geroscience. 2023. PMID: 36692591 Free PMC article.
-
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele.Brain Pathol. 2024 Jan;34(1):e13208. doi: 10.1111/bpa.13208. Epub 2023 Aug 30. Brain Pathol. 2024. PMID: 37646624 Free PMC article. Review.
-
Association of Late-Onset Unprovoked Seizures of Unknown Etiology With the Risk of Developing Dementia in Older Veterans.JAMA Neurol. 2020 Jun 1;77(6):710-715. doi: 10.1001/jamaneurol.2020.0187. JAMA Neurol. 2020. PMID: 32150220 Free PMC article.
-
Neuronal Hyperactivation in EEG Data during Cognitive Tasks Is Related to the Apolipoprotein J/Clusterin Genotype in Nondemented Adults.Int J Mol Sci. 2023 Apr 5;24(7):6790. doi: 10.3390/ijms24076790. Int J Mol Sci. 2023. PMID: 37047762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
